Amgen and Entera Bio call off oral drug delivery partnership after four years
Amgen and Entera Bio are calling off a four-year research collaboration “out of mutual convenience,” Entera revealed in its first-quarter results.
The Jerusalem-based biotech is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
